Healthcare provider profile · identity verified

Jonathan L Grief, M.D.

Family Practice · NEW ALBANY, IN · NPI 1548281967

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	558	134
Levothyroxine Sodium	Levothyroxine Sodium	547	113
Rosuvastatin Calcium	Rosuvastatin Calcium	530	132
Amlodipine Besylate	Amlodipine Besylate	474	120
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	464	75
Lisinopril	Lisinopril	341	98
Metoprolol Succinate	Metoprolol Succinate	248	71
Omeprazole	Omeprazole	248	71
Pantoprazole Sodium	Pantoprazole Sodium	237	59
Alprazolam	Alprazolam	234	42
Glimepiride	Glimepiride	224	59
Gabapentin	Gabapentin	208	50
Meloxicam	Meloxicam	207	54
Losartan Potassium	Losartan Potassium	196	61
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	191	49
Montelukast Sodium	Montelukast Sodium	184	41
Albuterol Sulfate Hfa	Albuterol Sulfate	166	40
Potassium Chloride	Potassium Chloride	156	39
Furosemide	Furosemide	152	37
Metformin Hcl Er	Metformin Hcl	151	45
Clopidogrel	Clopidogrel Bisulfate	145	29
Metformin Hcl	Metformin Hcl	138	38
Sertraline Hcl	Sertraline Hcl	137	34
Hydrochlorothiazide	Hydrochlorothiazide	134	35
Zolpidem Tartrate	Zolpidem Tartrate	133	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	132	26
Simvastatin	Simvastatin	130	37
Pioglitazone Hcl	Pioglitazone Hcl	129	33
Famotidine	Famotidine	108	30
Tamsulosin Hcl	Tamsulosin Hcl	107	26
Trazodone Hcl	Trazodone Hcl	103	28
Atenolol	Atenolol	102	28
Escitalopram Oxalate	Escitalopram Oxalate	101	25
Duloxetine Hcl	Duloxetine Hcl	100	22
Metoprolol Tartrate	Metoprolol Tartrate	95	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	90	21
Allopurinol	Allopurinol	84	21
Tramadol Hcl	Tramadol Hcl	84	26
Citalopram Hbr	Citalopram Hydrobromide	83	20
Jardiance	Empagliflozin	79	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	75	17
Hydralazine Hcl	Hydralazine Hcl	73	19
Shingrix	Varicella-Zoster Ge/As01b/Pf	73	66
Eliquis	Apixaban	71	14
Alendronate Sodium	Alendronate Sodium	70	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	68	20
Synthroid	Levothyroxine Sodium	68	23
Testosterone Cypionate	Testosterone Cypionate	66	12
Hydroxyzine Hcl	Hydroxyzine Hcl	65	16
Doxycycline Hyclate	Doxycycline Hyclate	64	52
Bupropion Xl	Bupropion Hcl	63	12
Ropinirole Hcl	Ropinirole Hcl	62	13
Clonazepam	Clonazepam	60	12
Fluoxetine Hcl	Fluoxetine Hcl	57	11
Fluticasone Propionate	Fluticasone Propionate	56	18
Aripiprazole	Aripiprazole	51	12
Ozempic	Semaglutide	51	suppressed
Lovastatin	Lovastatin	50	13
Pregabalin	Pregabalin	50	11
Temazepam	Temazepam	50	suppressed
Trulicity	Dulaglutide	50	11
Tradjenta	Linagliptin	49	suppressed
Azithromycin	Azithromycin	48	41
Lorazepam	Lorazepam	45	suppressed
Solifenacin Succinate	Solifenacin Succinate	43	suppressed
Buspirone Hcl	Buspirone Hcl	42	11
Tizanidine Hcl	Tizanidine Hcl	41	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	31
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Warfarin Sodium	Warfarin Sodium	40	suppressed
Ezetimibe	Ezetimibe	39	suppressed
Oxycodone Hcl	Oxycodone Hcl	39	suppressed
Bumetanide	Bumetanide	38	17
Celecoxib	Celecoxib	38	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	suppressed
Prednisone	Prednisone	37	34
Donepezil Hcl	Donepezil Hcl	36	suppressed
Carvedilol	Carvedilol	35	suppressed
Spironolactone	Spironolactone	35	11
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Memantine Hcl	Memantine Hcl	34	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Klor-Con M20	Potassium Chloride	33	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	32	suppressed
Fenofibrate	Fenofibrate	32	12
Diclofenac Sodium	Diclofenac Sodium	31	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	11
Ondansetron Hcl	Ondansetron Hcl	31	11
Glipizide Er	Glipizide	29	suppressed
Sucralfate	Sucralfate	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Methylprednisolone	Methylprednisolone	28	26
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	27	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	27	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Diazepam	Diazepam	26	suppressed
Myrbetriq	Mirabegron	26	suppressed
Telmisartan	Telmisartan	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Amoxicillin	Amoxicillin	22	21
Baclofen	Baclofen	21	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Glipizide	Glipizide	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Ondansetron Odt	Ondansetron	21	13
Propranolol Hcl	Propranolol Hcl	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Liothyronine Sodium	Liothyronine Sodium	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Topiramate	Topiramate	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Gemtesa	Vibegron	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Carisoprodol	Carisoprodol	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	12
Fluconazole	Fluconazole	16	12
Olanzapine	Olanzapine	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Estradiol	Estradiol	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Fentanyl	Fentanyl	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Nystatin	Nystatin	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Primidone	Primidone	12	suppressed
Prozac	Fluoxetine Hcl	12	suppressed
Roflumilast	Roflumilast	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Belsomra	Suvorexant	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Nurtec Odt	Rimegepant Sulfate	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed
Theo-24	Theophylline Anhydrous	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error